HRT Financial’s CONMED CNMD Stock Holding History

HRT Financial’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$762K	Buy	21,550 +737	+4%	+$30K	﹤0.01%	2227
2025 Q4	$845K	Buy	+20,813	New	+$905K	﹤0.01%	1825
2025 Q3	–	Sell	-8,268	Closed	-$430K	–	2957
2025 Q2	$430K	Buy	+8,268	New	+$454K	﹤0.01%	1674
2024 Q4	–	Sell	-31,458	Closed	-$2.26M	–	2529
2024 Q3	$2.26M	Buy	+31,458	New	+$2.22M	0.01%	833
2024 Q2	–	Sell	-4,671	Closed	-$374K	–	2330
2024 Q1	$374K	Sell	4,671 -11,105	-70%	-$990K	﹤0.01%	1417
2023 Q4	$1.73M	Buy	+15,776	New	+$1.63M	0.01%	720
2022 Q3	–	Sell	-8,839	Closed	-$846K	–	2886
2022 Q2	$846K	Buy	+8,839	New	+$1.06M	0.01%	1060
2021 Q4	–	Sell	-11,647	Closed	-$1.52M	–	3304
2021 Q3	$1.52M	Buy	+11,647	New	+$1.52M	0.01%	922
2020 Q4	–	Sell	-8,807	Closed	-$692K	–	1934
2020 Q3	$692K	Buy	+8,807	New	+$718K	0.02%	733
2020 Q1	–	Sell	-2,292	Closed	-$256K	–	849
2019 Q4	$256K	Buy	+2,292	New	+$244K	0.01%	823

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

HRT Financial's CNMD Position: Q1 2026 in Review

HRT Financial increased its CONMED (CNMD) stake by 3.5% in Q1 2026, buying an estimated $30K and bringing the position to 21,550 shares worth $762K. The position accounts for ﹤0.01% of the portfolio, ranked #2227.

HRT Financial first reported a position in CNMD in Q4 2019 and has held it in 10 quarters since. The position peaked at $2.26M in Q3 2024. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

HRT Financial held 21,550 shares of CONMED worth $762K as of Q1 2026.
HRT Financial bought 737 CONMED shares in Q1 2026, an estimated $30K.
CONMED made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #2227 holding.
HRT Financial first reported a position in CONMED in Q4 2019 and has held it in 10 quarters since.
HRT Financial's CONMED position peaked at $2.26M in Q3 2024.
236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.